UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 104

Sortiert nach

EP-1332 A NOVEL METHOD FOR EBT2 RADIOCHROMIC FILM DOSIMETRY

Radiotherapy and oncology, 2012-05, Vol.103, p.S506-S506

2012

Link zum Volltext

Verfügbarkeit prüfen

PO-1366 Inter-observer variation in GTV delineation of esophageal cancer on MR, CT and PET CT

Radiotherapy and oncology, 2023-05, Vol.182, p.S1096-S1097

2023

Link zum Volltext

Verfügbarkeit prüfen

822O Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial)

Annals of oncology, 2023-10, Vol.34, p.S543-S543

2023

Link zum Volltext

Verfügbarkeit prüfen

SU-F-T-551: Beam Hardening and Attenuation of Photon Beams Using Integral Quality Monitor in Radiotherapy

Medical physics (Lancaster), 2016-06, Vol.43 (6), p.3590-3590

2016

Link zum Volltext

Verfügbarkeit prüfen

EP-1760: A simple method for estimating the longitudinal isocentre shift due to gantry motion

Radiotherapy and oncology, 2017-05, Vol.123, p.S969-S969

2017

Link zum Volltext

Verfügbarkeit prüfen

IAEA survey on image-guided radiotherapy protocols and doses in the European region

Physica medica, 2021-12, Vol.92, p.S140

2021

Link zum Volltext

Verfügbarkeit prüfen

OD182 - IAEA survey on image-guided radiotherapy protocols and doses in the European region

Physica medica, 2021-12, Vol.92, p.S140-S140

2021

Link zum Volltext

Verfügbarkeit prüfen

Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III

Leukemia research, 2021-09, Vol.108, p.106681, Article 106681.51

2021

Link zum Volltext

Verfügbarkeit prüfen

P52 - Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM

Leukemia research, 2021-09, Vol.108

2021

Link zum Volltext

Verfügbarkeit prüfen

Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation

Leukemia research, 2021-09, Vol.108, p.106681, Article 106681.55

2021

Link zum Volltext

Verfügbarkeit prüfen

Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III

Leukemia research, 2021-09, Vol.108, p.106680, Article 106680.11

2021

Link zum Volltext

Verfügbarkeit prüfen

O24 - Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM

Leukemia research, 2021-09, Vol.108

2021

Link zum Volltext

Verfügbarkeit prüfen

Maladie de Rosaï-Dorfman-Destombes disséminée réfractaire associée à une myélodysplasie. Efficacité du traitement hématologique

La revue de medecine interne, 2019-12, Vol.40, p.A124-A124

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacité et tolérance de l’azacitidine au cours du syndrome VEXAS avec et sans syndrome myélodysplasique : données du registre français

La revue de medecine interne, 2023-12, Vol.44, p.A356-A357

2023

Link zum Volltext

Verfügbarkeit prüfen

On multichannel film dosimetry with channel-independent perturbations

Medical physics (Lancaster), 2014-01, Vol.41 (1)

2014

Link zum Volltext

Verfügbarkeit prüfen

Determining membrane permeability of giant phospholipid vesicles from a series of videomicroscopy images

Measurement science & technology, 2009-05, Vol.20 (5), p.055801

2009

Link zum Volltext

Verfügbarkeit prüfen

Impact of pre-transplant diffusion lung capacity for nitric oxide ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases

Bone marrow transplantation (Basingstoke), 2016-04, Vol.51 (4), p.589

2016

Link zum Volltext

Verfügbarkeit prüfen

Caractéristiques cliniques, évolution et prise en charge des thrombopénies immunologiques associées aux syndromes myélodysplasiques et leucémies myélomonocytaires chroniques : une étude multicentrique rétrospective comparative

La revue de medecine interne, 2019-12, Vol.40, p.A36-A37

2019

Link zum Volltext

Verfügbarkeit prüfen

85 - Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment

Leukemia research, 2017-04, Vol.55, p.S54-S54

2017

Link zum Volltext

Verfügbarkeit prüfen

PB2146 SINGLE AGENT DARATUMUMAB IN VERY ADVANCED RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL‐LIFE SINGLE CENTER RETROSPECTIVE STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.965-966

2019

Link zum Volltext

Verfügbarkeit prüfen

PF651 POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN A REAL LIFE SETTING: A SINGLE CENTER RETROSPECTIVE STUDY

HemaSphere, 2019-06, Vol.3 (S1), p.279-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

PF263 DEEP RESPONSE AFTER CPX‐351 TREATMENT IN T‐AML AND MRC‐AML: A REPORT FROM A MULTICENTRIC FRENCH COHORT

HemaSphere, 2019-06, Vol.3 (S1), p.83-84

2019

Link zum Volltext

Verfügbarkeit prüfen

Évaluation de la capacité physique des patients allogreffés de cellules souches hématopoïétiques : le test de marche de 6 minutes ne suffit pas

Revue des maladies respiratoires, 2017-01, Vol.34, p.A71-A71

2017

Link zum Volltext

Verfügbarkeit prüfen

Évaluation de la capacité physique des patients allogreffés de cellules souches hématopoïétiques : le test de marche de 6minutes ne suffit pas

Revue des maladies respiratoires, 2017-01, Vol.34, p.A71

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 104

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Humans
(10)
Physical Sciences
(7)
Animals
(6)
Biological And Medical Sciences
(6)
Human Immunodeficiency Virus
(6)
Multidisciplinary Sciences
(6)
Science & Technology - Other Topics
(6)
Aids/hiv
(5)
Fundamental And Applied Biological Sciences. Psychology
(5)
Hiv
(5)
Polymer Science
(5)
Proteins
(5)
Aids
(4)
Cell Line
(4)
Genes, Viral
(4)
Hiv - Genetics
(4)
Human Immunodeficiency Virus 1
(4)
Plasmids
(4)
Acquired Immune Deficiency Syndrome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EP-1332 A NOVEL METHOD FOR EBT2 RADIOCHROMIC FILM DOSIMETRY

PO-1366 Inter-observer variation in GTV delineation of esophageal cancer on MR, CT and PET CT

822O Activation of γ9δ2 T cells by ICT01 as a novel immunotherapeutic approach for relapsed/refractory hematologic cancers (EVICTION trial)

SU-F-T-551: Beam Hardening and Attenuation of Photon Beams Using Integral Quality Monitor in Radiotherapy

EP-1760: A simple method for estimating the longitudinal isocentre shift due to gantry motion

IAEA survey on image-guided radiotherapy protocols and doses in the European region

OD182 - IAEA survey on image-guided radiotherapy protocols and doses in the European region

Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III

P52 - Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: EFFICACY OF CPX-351 AS FIRST LINE TREATMENT FOR HIGHER RISK (HR) MDS/CMML. A STUDY BY THE GFM

P56 - Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation: COMPARABLE OUTCOMES AMONG ADULT PATIENTS ALLOTRANSPLANTED FOR MYELODYSPLASTIC SYNDROME USING HAPLOIDENTICAL, MATCHED UNRELATED OR MATCHED SIBLING DONORS: A SINGLE-CENTER STUDY

Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation -Bridging to transplantation

Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III

O24 - Topic: AS08-Treatment/AS08g-Clinical trials - Phase II-III: APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM

Maladie de Rosaï-Dorfman-Destombes disséminée réfractaire associée à une myélodysplasie. Efficacité du traitement hématologique

Efficacité et tolérance de l’azacitidine au cours du syndrome VEXAS avec et sans syndrome myélodysplasique : données du registre français

On multichannel film dosimetry with channel-independent perturbations

Determining membrane permeability of giant phospholipid vesicles from a series of videomicroscopy images

Impact of pre-transplant diffusion lung capacity for nitric oxide ratio on pulmonary outcomes in adults receiving allogeneic stem cell transplantation for hematological diseases

Caractéristiques cliniques, évolution et prise en charge des thrombopénies immunologiques associées aux syndromes myélodysplasiques et leucémies myélomonocytaires chroniques : une étude multicentrique rétrospective comparative

85 - Results of a Phase II Study of Guadecitabine in Higher Risk MDS Patients Refractory to or Relapsing after Azacitidine Treatment

PB2146 SINGLE AGENT DARATUMUMAB IN VERY ADVANCED RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS: A REAL‐LIFE SINGLE CENTER RETROSPECTIVE STUDY

PF651 POMALIDOMIDE, CYCLOPHOSPHAMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA PATIENTS IN A REAL LIFE SETTING: A SINGLE CENTER RETROSPECTIVE STUDY

PF263 DEEP RESPONSE AFTER CPX‐351 TREATMENT IN T‐AML AND MRC‐AML: A REPORT FROM A MULTICENTRIC FRENCH COHORT

Évaluation de la capacité physique des patients allogreffés de cellules souches hématopoïétiques : le test de marche de 6 minutes ne suffit pas

Évaluation de la capacité physique des patients allogreffés de cellules souches hématopoïétiques : le test de marche de 6minutes ne suffit pas

Aktive Filter

Suchergebnisse filtern